Insider buying
3 insiders in a week, 6th time since 2007Traded Nov 13 · filed the same day
Since the trade −19.1% · S&P 500 −8.6% · to Nov 20
Bought within 3% of the 52-week low, RSI 27, 48% under its 200-day average, 41 points behind the S&P 500 over 3 months
The CEO of Altimmune paid $50K out of pocket for Altimmune shares. 3 other people at Altimmune bought some too, in the same month. It was the first purchase in over a year.
Lately at Altimmune: it reported its results on Nov 12; the stock is down 40% in 30 days; insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.